Oncocyte Begins Manufacturing Transplant Blood Test

Oncocyte Begins Manufacturing Transplant Blood Test OncoCyte, Corp. (Nasdaq: OCX), a precision diagnostics company, has announced that it has started the manufacturing process for its patented transplant technology. The test measures levels of donor derived cell-free DNA (dd-cfDNA) in the blood to check for signs of graft damage in transplant recipients. The company plans to launch an early acce..